Colgate-Palmolive Company (CL) Monthly Overview
Publication Date: September 22, 2024
Company Overview
Colgate-Palmolive Company (CL), a longstanding giant in the Consumer Defensive sector, is strategically headquartered in New York City. Founded in 1806, the company primarily operates through two distinct segments: Oral, Personal and Home Care, and Pet Nutrition. With a portfolio featuring esteemed brands like Colgate, Palmolive, and Hill’s Science Diet, Colgate-Palmolive caters to both human and pet nutritional needs. The stock has garnered attention from investors keen on stable consumer staples, and the recent market conditions suggest that a buy recommendation is firmly supported due to its projected growth. Currently, CL is trading at $103.06, with analysts targeting a high price of $122.00, reflecting an optimistic outlook on its valuation.
Financial Performance and Market Dynamics
In its latest financial report, Colgate-Palmolive recorded an impressive total revenue of approximately $19.99 billion, underscoring the company’s robust market position and strong consumer demand. With 817,086,976 shares outstanding and only 8,701,345 shares sold short (approximately 0.0107 percent of the float), the data indicates a cautious sentiment towards the stock among traders. Notably, the low short percent suggests limited bearish sentiment, which could signal potential stability moving forward.
Industry analysts have expressed a generally favorable outlook for Colgate-Palmolive, as evidenced by a mean target price of $105.78 and significant upside potential with a projected high of $122.00. The stock price sits just above its fifty-day moving average of $102.55, signaling a bullish trend as it approaches its fifty-two week high of $109.30. With a recent low of $67.62 within the past year, the stock displays considerable growth potential while highlighting the need for close monitoring of price movements.
Analyst Consensus and Price Projections
The consensus among 21 analysts leans towards a “buy” recommendation for Colgate-Palmolive, marked by a mean rating of 2.4. The established target price range, with a high of $122.00 and a low of $90.00, portrays a robust growth outlook in the near term. Additionally, the median target price of $106.00 reinforces a positive sentiment regarding the stock’s performance. These assessments, complemented by strong revenue figures, make Colgate-Palmolive a compelling investment opportunity amidst the evolving market landscape.
In summary, Colgate-Palmolive’s solid financial metrics, combined with favorable analyst sentiments, underpin its potential for continued growth, making it a stock worth considering for investors focused on stability and value.
| Metric | Value |
|---|---|
| Market Cap | $84.2b |
| Total Debt | $8.7b |
| Total Cash | $1.3b |
| Shares Outstanding | 817.1m |
| Float Shares | 768.6m |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.